[1]
|
The Royal Society and the Royal Academy of Engineering (2014) Nanoscience and Nanotechnologies. The Royal Society and the Royal Academy of Engineering Report. http:/www.nanotec.org.uk/finalReport.htm
|
[2]
|
Stylios, G.K., Giannoudis, P.V. and Wan, T. (2005) Applications of Nanotechnologies in Medical Practice. Injury, 36, S6-S13.
|
[3]
|
Nelson, A.O., Patrick, O.O. and Ndidi, C.N. (2009) Nanotechnology and Drug Delivery. Part 1: Background and Applications. Tropical Journal of Pharmaceutical Research, 8, 265-274.
|
[4]
|
Taniguchi, N. (1974) Proc Int Conf Prod Eng, Part II, Japan Society of Precision Engineering, Tokyo.
|
[5]
|
Nanotechnology, K.P. (2007) What It Can Do for Drug Delivery. Journal of Controlled Release, 120, 1-3. http://dx.doi.org/10.1016/j.jconrel.2007.05.003
|
[6]
|
The Nanotechnology Opportunity Report 2008. 3rd Edition. www.cientifica.com
|
[7]
|
Panyam, J. and Labhasetwar, V. (2003) Biogradebale Nanoparticle for Drug and Gene Delivery to Cells and Tissue. Advanced Drug Delivery Reviews, 55, 329-347. http://dx.doi.org/10.1016/S0169-409X(02)00228-4
|
[8]
|
Italia, J.L., Bhatt, D.K., Bhardwaj, V., Tikoo, K. and Ravi, K. (2007) PLGA Nanoparticle for Oral Delivery of Cyclosporine: Nephrotoxicity and Pharmacokinetic Studies in Comparison to Sandimmune Neural. Journal of Controlled Release, 119, 197-206. http://dx.doi.org/10.1016/j.jconrel.2007.02.004
|
[9]
|
Sahoo, S.K. and Labhasetwar, V. (2003) Nanotech Approaches to Drug Delivery and Imaging. Drug Discovery Today, 8, 1112-1120. http://dx.doi.org/10.1016/S1359-6446(03)02903-9
|
[10]
|
Peppas, N.A. (2004) Intellegent Therapeutics: Biomimetic Systems and Nanotechnology in Drug Delivery. Advanced Drug Delivery Reviews, 56, 1529-1531. http://dx.doi.org/10.1016/j.addr.2004.07.001
|
[11]
|
University of Waterloo (2010) Nanotechnology in Targeted Cancer Therapy. http://www.youtube.com/watch?v=RBjWwlnq3cA
|
[12]
|
Lavan, D.A., McGuire, T. and Langer, R. (2003) Small Scale Systems for in Vivo Drug Delivery. Nature Biotechnology, 21, 1184-1191. http://dx.doi.org/10.1038/nbt876
|
[13]
|
Cavalcanti, A., Shirinzadeh, B., Freitas Jr., R.A. and Hogg, T. (2008) Nanorobot Architecture for Medical Target Identification. Nanotechnology, 19, Article ID: 015103. http://dx.doi.org/10.1088/0957-4484/19/01/015103
|
[14]
|
Gonsalves, K.E., et al. (2008) Biomedical Nanostructures. John Wiley & Sons, Inc., Hoboken, New York, USA.
|
[15]
|
Brigger, I., Dubernet, C. and Couvreur, P. (2002) Nanoparticles in Cancer Therapy and Diagnosis. Advanced Drug Delivery Reviews, 54, 631-651. http://dx.doi.org/10.1016/S0169-409X(02)00044-3
|
[16]
|
Prasad, P.V., Kumar, A., Pal, P.C., Sharma, R.S., Rao, D.N., Shrivastav, T.G. and Ge, R.-S. (2011) Bird’s Eye View on the Recent Advances in Drug Delivery Systems. Journal of Biomaterials and Nanobiotechnology, 2, 544-556. http://dx.doi.org/10.4236/jbnb.2011.225065
|
[17]
|
Santos-Magalhaes, N.S., Pontes, A., Pereira, V.M.W. and Caetano, M.N.P. (2000) Colloidal Carriers for Benzathin Penicillin G: Nanoemulsion and Nanocapsules. International Journal of Pharmaceutics, 208, 71-80. http://dx.doi.org/10.1016/S0378-5173(00)00546-9
|
[18]
|
Brusewitz, C., Schendler, A., Funke, A., Wagner, T. and Lipp, R. (2007) Novel Poloxamer-Based Nanoemulsions to Enhance the Intestinal Absorption of Active Compunds. International Journal of Pharmaceutics, 329, 1173-1181. http://dx.doi.org/10.1016/j.ijpharm.2006.08.022
|
[19]
|
Chiesa, M., Garg, J., Kang, Y.T. and Cheng, G. (2008) Thermal Conductivity and Viscosity of Water-in-Oil Nanoemulsions. Colloids and Surfaces A: Physicochemical and Engineering Aspects, 326, 67-72.
|
[20]
|
Anju, S., Senthil, K. and Mahadevan, N. (2012) Nanotechnology: A Promising Approach for Cosmetics. International Journal of Advances in Pharmaceutical Research, 2, 54-61.
|
[21]
|
Soppimath, K.S., Aminbhavi, T.M., Kulkarni, A.R. and Rudzinski, W.E. (2001) Biogradedable Polymeric Nanoparticles as Drug Delivery Devices. Journal of Recent Controlled Release, 70, 1-20. http://dx.doi.org/10.1016/S0168-3659(00)00339-4
|
[22]
|
Qiu, Y., Gao, Y., Hu, K. and Li, F. (2008) En-hancement of Skin Permeation of Docetaxel: A Novel Approach Combining Micro Needle and Elastic Liposomes. Journal of Controlled Release, 129, 144-150. http://dx.doi.org/10.1016/j.jconrel.2008.04.019
|
[23]
|
Jia, Y., Joly, H. and Omri, H. (2008) Liposomes as a Carrier for Gentamicin Delivery: Development and Evaluation of the Physio-chemical Properties. International Journal of Pharmaceutics, 359, 254-263. http://dx.doi.org/10.1016/j.ijpharm.2008.03.035
|
[24]
|
Zaru, M., Mourtas, S., Klepetsanis, P., Fadda, A.M. and Antimisiaris, S.G. (2007) Liposomes for Drug Delivery to the Lungs by Nebulization. European Journal of Pharmaceutics and Biopharmaceutics, 76, 655-666. http://dx.doi.org/10.1016/j.ejpb.2007.04.005
|
[25]
|
Kulkarni, P.R., Yadav, J.D., Vaidya, K.A. and Gandhi, P.P. (2011) Transferosomes: An Emerging Tool for Transdermal Drug Delivery. IJPSR, 2, 735-741.
|
[26]
|
Pandey, S., Goyani, M., Devmurari, V. and Fakir, J. (2009) Transferosomes: A Novel Approach for Transdermal Drug Delivery. Der Pharmacia Lettre, 1, 143-150.
|
[27]
|
Svenson, S. and Tomalia, D.A. (2005) Dendrimers in Biomedical Applications-Reflections on the Field. Advanced Drug Delivery Review, 57, 2106-2129. http://dx.doi.org/10.1016/j.addr.2005.09.018
|
[28]
|
Nelson, A.O., Patrick, O.O. and Ndidi, C.N. (2009) Nanotechnology and Drug Delivery. Part 2: Nanostructures for Drug Delivery. Tropical Journal of Pharmaceutical Research, 8, 275-287.
|
[29]
|
Boas, U. and Heegaard, P.M.H. (2004) Dendrimers in Drug Research. Chemical Society Reviews, 33, 43-63. http://dx.doi.org/10.1039/b309043b
|
[30]
|
Fischer, D., Li, Y.X., Ahlemeyer, J., Krieglstein, J. and Kissel, T. (2004) In Vitro Cytotoxicity Testing of Polycations: Influence of Polymer Structure on Cell Viability and Hemolysis. Biomaterials, 24, 1121-1131. http://dx.doi.org/10.1016/S0142-9612(02)00445-3
|
[31]
|
Malik, N., Wiwattananpatapee, R., Klopsche, R., Lorenz, K., Frey, H., Weener, J.W., Meijer, E.W., Paulus, W. and Duncan, R. (2000) Dendimers: Relationship between Structure and Biocompatibility in Vitro, and Preliminary Studies on the Biodistribution of 125I-Labelled Polyamidoamine Dendrimers in Vivo. Journal of Controlled Release, 65, 133-148. http://dx.doi.org/10.1016/S0168-3659(99)00246-1
|
[32]
|
Yih, T.C. and Al-Fandi, M. (2006) Engineered Nanoparticles as Precise Drug Delivery Systems. Journal of Cellular Biochemistry, 97, 1184-1190. http://dx.doi.org/10.1002/jcb.20796
|
[33]
|
Jain, T.K., Roy, I., De, T.K. and Maitra, A. (1998) Nanometer Silica Particles Encapsulating Active Compunds: A Novel Ceramic Drug Carrier. Journal of the American Chemical Society, 120, 11092-11095. http://dx.doi.org/10.1021/ja973849x
|
[34]
|
Medina, C., Santos, M.J., Radomski, A., Corrigan, O. and Radomski, M.W. (2007) Nanoparticles: Pharmacological and Toxicological Significance. British Journal of Pharmacology, 150, 552-558.
|
[35]
|
Wissing, S.A., Kayser, O. and Muller, R.H. (2004) Solid Lipid Nanoparticles for Parenteral Drug Delivery. Advanced Drug Delivery Reviews, 56, 1257-1272. http://dx.doi.org/10.1016/j.addr.2003.12.002
|
[36]
|
Godin, B. and Touitou, E. (2003) Ethosomes: New Prospects in Transdermal Delivery. Critical Reviews in Therapeutic Drug Carrier Systems, 20, 63-102.
|
[37]
|
Jain, S., Umamaheshwari, R.B., Bhadra, D. and Jain, N.K. (2004) Ethosomes: A Novel Vesicular Carrier for Enhanced Transdermal Delivery of an Anti-HIV Agent. Indian Journal of Pharmaceutical Sciences, 66, 72-81.
|
[38]
|
Mnyusiwalla, A., Daar, A.S. and Singer, P.A. (2003) Mind the Gap: Science and Ethics in Nanotechnology. Nanotechnology, 14, R9-R13. http://dx.doi.org/10.1088/0957-4484/14/3/201
|
[39]
|
Basi, C. (2013) Toxic Nanoparticles Might Be Entering Human Food Supply. MU Study Finds, University of Missouri, Columbia.
|
[40]
|
Jackie, Y. (2001) Nanostructured Materials. Academic Press, New York.
|
[41]
|
Nanotechnologies: 6. What Are Potential Harmful Effects of Nanoparticles? (ec.europa.eu)
|